We systematically evaluated the prognostic utility of glycocalyx‐associated biomarkers (syndecan‐1, heparan sulfate, hyaluronate) and the endothelial activation marker endocan in sepsis with respect to mortality, organ dysfunction, and inter‐study heterogeneity. The gene discussed is ESM1; the disease is Sepsis.